Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
1.
Clin Exp Allergy ; 51(8): 1019-1032, 2021 08.
Artículo en Inglés | MEDLINE | ID: mdl-33866615

RESUMEN

BACKGROUND: Omalizumab and Mepolizumab are biologic drugs with proven efficacy in clinical trials. However, a better understanding of their real-world effectiveness in severe asthma management is needed. OBJECTIVES: To better understand the real-world effectiveness of Omalizumab and Mepolizumab, elucidate the clinical phenotypes of patients treated with these drugs, identify baseline characteristics associated with biologic response and assess the spectrum of responses to these medications. METHODS: Using real-world clinical data, we retrospectively phenotyped biologic naïve patients from the Wessex AsThma CoHort of difficult asthma (N = 478) commenced on Omalizumab (N = 105) or Mepolizumab (N = 62) compared to severe asthma patients not receiving biologics (SNB, N = 178). We also assessed multiple clinical endpoints and identified features associated with response. RESULTS: Compared to SNB, Omalizumab patients were younger, diagnosed with asthma earlier, and more likely to have rhinitis. Conversely, compared to SNB, Mepolizumab patients were predominantly older males, diagnosed with asthma later, and more likely to have nasal polyposis but less dysfunctional breathing. Both treatments reduced exacerbations, Acute Healthcare Encounters [AHE] (emergency department or hospital admissions), maintenance oral corticosteroid dose, and improved Asthma Control Questionnaire 6 (ACQ6) scores. Omalizumab response was independently associated with more baseline exacerbations (p = .024) but fewer AHE (p = .050) and absence of anxiety (p = .008). Lower baseline ACQ6 was independently associated with Mepolizumab response (p = .007). A composite group of non-responders demonstrated significantly more psychopathologies and worse baseline subjective disease compared to responder groups. CONCLUSIONS AND CLINICAL RELEVANCE: In a difficult asthma cohort, Omalizumab and Mepolizumab were used in distinct clinical phenotypes but were both multidimensionally efficacious. Certain baseline clinical characteristics were associated with poorer biologic responses, such as psychological co-morbidity, which may assist clinicians in biologic selection. These characteristics also emphasize the need for comprehensive approaches to support these patients.


Asunto(s)
Antiasmáticos/uso terapéutico , Anticuerpos Monoclonales Humanizados/uso terapéutico , Asma/tratamiento farmacológico , Omalizumab/uso terapéutico , Adulto , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Fenotipo , Estudios Retrospectivos , Resultado del Tratamiento
2.
Eur Respir J ; 51(5)2018 05.
Artículo en Inglés | MEDLINE | ID: mdl-29700102

RESUMEN

Bronchial thermoplasty is a treatment for asthma. It is currently unclear whether its histopathological impact is sufficiently explained by the proportion of airway wall that is exposed to temperatures necessary to affect cell survival.Airway smooth muscle and bronchial epithelial cells were exposed to media (37-70°C) for 10 s to mimic thermoplasty. In silico we developed a mathematical model of airway heat distribution post-thermoplasty. In vivo we determined airway smooth muscle mass and epithelial integrity pre- and post-thermoplasty in 14 patients with severe asthma.In vitro airway smooth muscle and epithelial cell number decreased significantly following the addition of media heated to ≥65°C. In silico simulations showed a heterogeneous heat distribution that was amplified in larger airways, with <10% of the airway wall heated to >60°C in airways with an inner radius of ∼4 mm. In vivo at 6 weeks post-thermoplasty, there was an improvement in asthma control (measured via Asthma Control Questionnaire-6; mean difference 0.7, 95% CI 0.1-1.3; p=0.03), airway smooth muscle mass decreased (absolute median reduction 5%, interquartile range (IQR) 0-10; p=0.03) and epithelial integrity increased (14%, IQR 6-29; p=0.007). Neither of the latter two outcomes was related to improved asthma control.Integrated in vitro and in silico modelling suggest that the reduction in airway smooth muscle post-thermoplasty cannot be fully explained by acute heating, and nor did this reduction confer a greater improvement in asthma control.


Asunto(s)
Asma/terapia , Termoplastia Bronquial/métodos , Células Epiteliales/metabolismo , Modelos Biológicos , Músculo Liso/patología , Adulto , Anciano , Remodelación de las Vías Aéreas (Respiratorias) , Apoptosis , Termoplastia Bronquial/efectos adversos , Broncoscopía , Simulación por Computador , Femenino , Humanos , Masculino , Persona de Mediana Edad
3.
J Immunol ; 194(12): 6144-54, 2015 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-25934861

RESUMEN

Influenza A virus causes considerable morbidity and mortality largely because of a lack of effective antiviral drugs. Viral neuraminidase inhibitors, which inhibit viral release from the infected cell, are currently the only approved drugs for influenza, but have recently been shown to be less effective than previously thought. Growing resistance to therapies that target viral proteins has led to increased urgency in the search for novel anti-influenza compounds. However, discovery and development of new drugs have been restricted because of differences in susceptibility to influenza between animal models and humans and a lack of translation between cell culture and in vivo measures of efficacy. To circumvent these limitations, we developed an experimental approach based on ex vivo infection of human bronchial tissue explants and optimized a method of flow cytometric analysis to directly quantify infection rates in bronchial epithelial tissues. This allowed testing of the effectiveness of TVB024, a vATPase inhibitor that inhibits viral replication rather than virus release, and to compare efficacy with the current frontline neuraminidase inhibitor, oseltamivir. The study showed that the vATPase inhibitor completely abrogated epithelial cell infection, virus shedding, and the associated induction of proinflammatory mediators, whereas oseltamivir was only partially effective at reducing these mediators and ineffective against innate responses. We propose, therefore, that this explant model could be used to predict the efficacy of novel anti-influenza compounds targeting diverse stages of the viral replication cycle, thereby complementing animal models and facilitating progression of new drugs into clinical trials.


Asunto(s)
Evaluación Preclínica de Medicamentos/métodos , Virus de la Influenza A/efectos de los fármacos , Gripe Humana/virología , Pulmón/efectos de los fármacos , Pulmón/virología , Técnicas de Cultivo de Órganos , Antivirales/administración & dosificación , Antivirales/farmacología , Citometría de Flujo , Humanos , Inmunofenotipificación , Virus de la Influenza A/fisiología , Gripe Humana/tratamiento farmacológico , Fenotipo
4.
Am J Respir Crit Care Med ; 194(1): 26-37, 2016 07 01.
Artículo en Inglés | MEDLINE | ID: mdl-26815632

RESUMEN

RATIONALE: Asthma is one of the most common chronic diseases worldwide, and individuals with severe asthma experience recurrent exacerbations. Exacerbations are predominantly viral associated and have been linked to defective airway IFN responses. Ascertaining the molecular mechanisms underlying this deficiency is a major research goal to identify new therapeutic targets. OBJECTIVES: We investigated the hypothesis that reduced Toll-like receptor 7 (TLR7)-derived signaling drove the impaired IFN responses to rhinovirus by asthmatic alveolar macrophages (AMs); the molecular mechanisms underlying this deficiency were explored. METHODS: AMs were recovered from bronchoalveolar lavage from healthy subjects and patients with severe asthma. Expression of pattern-recognition receptors and microRNAs was evaluated by quantitative polymerase chain reaction and Western blotting. A TLR7-luciferase reporter construct was created to evaluate binding of microRNAs to the 3' untranslated region of TLR7. IFN production was measured by quantitative polymerase chain reaction and ELISA. MEASUREMENTS AND MAIN RESULTS: The expression of TLR7 was significantly reduced in severe asthma AMs and was associated with reduced rhinovirus and imiquimod-induced IFN responses by these cells compared with healthy AMs. Severe asthma AMs also expressed increased levels of three microRNAs, which we showed were able to directly reduce TLR7 expression. Ex vivo knockdown of these microRNAs restored TLR7 expression with concomitant augmentation of virus-induced IFN production. CONCLUSIONS: In severe asthma, TLR7 deficiency drives impaired innate immune responses to virus by AMs. Blocking a group of microRNAs that are up-regulated in these cells can restore antiviral innate responses, providing a novel approach for therapy in asthma.


Asunto(s)
Asma/inmunología , MicroARNs/inmunología , Receptor Toll-Like 7/inmunología , Adolescente , Adulto , Anciano , Western Blotting , Líquido del Lavado Bronquioalveolar/inmunología , Femenino , Humanos , Inmunidad Innata/inmunología , Macrófagos Alveolares/inmunología , Masculino , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa , Índice de Severidad de la Enfermedad , Adulto Joven
5.
Eur Respir J ; 42(1): 87-97, 2013 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-23143548

RESUMEN

The airway epithelium forms a physical, chemical and immunological barrier against inhaled environmental substances. In asthma, these barrier properties are thought to be abnormal. In this study, we analysed the effect of grass pollen on the physical and immunological barrier properties of differentiated human primary bronchial epithelial cells. Following exposure to Timothy grass (Phleum pratense) pollen extract, the integrity of the physical barrier was not impaired as monitored by measuring the transepithelial resistance and immunofluorescence staining of tight junction proteins. In contrast, pollen exposure affected the immunological barrier properties by modulating vectorial mediator release. CXC chemokine ligand (CXCL)8/interleukin (IL)-8 showed the greatest increase in response to pollen exposure with preferential release to the apical compartment. Inhibition of the extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase pathways selectively blocked apical CXCL8/IL-8 release via a post-transcriptional mechanism. Apical release of CC chemokine ligand (CCL)20/macrophage inflammatory protein-3α, CCL22/monocyte-derived chemokine and tumour necrosis factor-α was significantly increased only in severe asthma cultures, while CCL11/eotaxin-1 and CXCL10/interferon-γ-induced protein-10 were reduced in nonasthmatic cultures. The bronchial epithelial barrier modulates polarised release of mediators in response to pollen without direct effects on its physical barrier properties. The differential response of cells from normal and asthmatic donors suggests the potential for the bronchial epithelium to promote immune dysfunction in asthma.


Asunto(s)
Asma/inmunología , Bronquios/patología , Células Epiteliales/patología , Extractos Vegetales/química , Polen/química , Alérgenos/química , Asma/metabolismo , Broncoscopía , Células Cultivadas , Quimiocinas/inmunología , Humanos , Inflamación , Interleucina-8/inmunología , Ligandos , Poaceae
8.
Emerg Med J ; 24(9): 682-3, 2007 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-17711965

RESUMEN

A case is presented of cardiac arrhythmia associated with varicella zoster infection, affecting a 34-year-old man. The patient presented with episodes of seizure-like activity, which were subsequently shown to be caused by ventricular fibrillation. The literature regarding this unusual complication of varicella zoster infection is discussed, as it affects both children and adults. Physicians who may face this condition, in accident and emergency, acute medicine, critical care medicine and infectious diseases, should all be aware of this serious complication.


Asunto(s)
Varicela/complicaciones , Convulsiones/virología , Fibrilación Ventricular/virología , Adulto , Amiodarona/uso terapéutico , Antiarrítmicos/uso terapéutico , Electrocardiografía , Humanos , Masculino , Convulsiones/tratamiento farmacológico , Convulsiones/fisiopatología , Fibrilación Ventricular/tratamiento farmacológico , Fibrilación Ventricular/fisiopatología
9.
Tissue Barriers ; 4(3): e1206378, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27583193

RESUMEN

The bronchial epithelium and underlying fibroblasts form an epithelial mesenchymal trophic unit (EMTU) which controls the airway microenvironment. We hypothesized that cell-cell communication within the EMTU propagates and amplifies the innate immune response to respiratory viral infections. EMTU co-culture models incorporating polarized (16HBE14o-) or differentiated primary human bronchial epithelial cells (HBECs) and fibroblasts were challenged with double-stranded RNA (dsRNA) or rhinovirus. In the polarized EMTU model, dsRNA affected ionic but not macromolecular permeability or cell viability. Compared with epithelial monocultures, dsRNA-stimulated pro-inflammatory mediator release was synergistically enhanced in the basolateral compartment of the EMTU model, with the exception of IL-1α which was unaffected by the presence of fibroblasts. Blockade of IL-1 signaling with IL-1 receptor antagonist (IL-1Ra) completely abrogated dsRNA-induced basolateral release of mediators except CXCL10. Fibroblasts were the main responders to epithelial-derived IL-1 since exogenous IL-1α induced pro-inflammatory mediator release from fibroblast but not epithelial monocultures. Our findings were confirmed in a differentiated EMTU model where rhinovirus infection of primary HBECs and fibroblasts resulted in synergistic induction of basolateral IL-6 that was significantly abrogated by IL-1Ra. This study provides the first direct evidence of integrated IL-1 signaling within the EMTU to propagate inflammatory responses to viral infection.


Asunto(s)
Comunicación Celular , Microambiente Celular , Células Epiteliales/metabolismo , Fibroblastos/metabolismo , Interleucina-1alfa/metabolismo , Mucosa Respiratoria/metabolismo , Permeabilidad Capilar , Línea Celular , Células Cultivadas , Quimiocina CXCL10/metabolismo , Células Epiteliales/virología , Fibroblastos/virología , Humanos , Mucosa Respiratoria/citología , Mucosa Respiratoria/virología , Rhinovirus/patogenicidad , Transducción de Señal
10.
Toxicol Sci ; 145(1): 98-107, 2015 May.
Artículo en Inglés | MEDLINE | ID: mdl-25673499

RESUMEN

We have previously shown that underground railway particulate matter (PM) is rich in iron and other transition metals across coarse (PM10-2.5), fine (PM2.5), and quasi-ultrafine (PM0.18) fractions and is able to generate reactive oxygen species (ROS). However, there is little knowledge of whether the metal-rich nature of such particles exerts toxic effects in mucus-covered airway epithelial cell cultures or whether there is an increased risk posed by the ultrafine fraction. Monolayer and mucociliary air-liquid interface (ALI) cultures of primary bronchial epithelial cells (PBECs) were exposed to size-fractionated underground railway PM (1.1-11.1 µg/cm(2)) and release of lactate dehydrogenase and IL-8 was assayed. ROS generation was measured, and the mechanism of generation studied using desferrioxamine (DFX) and N-acetylcysteine (NAC). Expression of heme oxygenase-1 (HO-1) was determined by RT-qPCR. Particle uptake was studied by transmission electron microscopy. Underground PM increased IL-8 release from PBECs, but this was diminished in mucus-secreting ALI cultures. Fine and ultrafine PM generated a greater level of ROS than coarse PM. ROS generation by ultrafine PM was ameliorated by DFX and NAC, suggesting an iron-dependent mechanism. Despite the presence of mucus, ALI cultures displayed increased HO-1 expression. Intracellular PM was observed within vesicles, mitochondria, and free in the cytosol. The results indicate that, although the mucous layer appears to confer some protection against underground PM, ALI PBECs nonetheless detect PM and mount an antioxidant response. The combination of increased ROS-generating ability of the metal-rich ultrafine fraction and ability of PM to penetrate the mucous layer merits further research.


Asunto(s)
Bronquios/efectos de los fármacos , Cilios/efectos de los fármacos , Material Particulado/toxicidad , Transportes , Bronquios/citología , Células Cultivadas , Células Epiteliales/citología , Humanos , Tamaño de la Partícula
11.
PLoS One ; 8(8): e71278, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24009658

RESUMEN

Sensitization and exposure to the allergenic fungus Alternaria alternata has been associated with increased risk of asthma and asthma exacerbations. The first cells to encounter inhaled allergens are epithelial cells at the airway mucosal surface. Epithelial barrier function has previously been reported to be defective in asthma. This study investigated the contribution of proteases from Alternaria alternata on epithelial barrier function and inflammatory responses and compared responses of in vitro cultures of differentiated bronchial epithelial cells derived from severely asthmatic donors with those from non-asthmatic controls. Polarised 16HBE cells or air-liquid interface (ALI) bronchial epithelial cultures from non-asthmatic or severe asthmatic donors were challenged apically with extracts of Alternaria and changes in inflammatory cytokine release and transepithelial electrical resistance (TER) were measured. Protease activity in Alternaria extracts was characterised and the effect of selectively inhibiting protease activity on epithelial responses was examined using protease inhibitors and heat-treatment. In 16HBE cells, Alternaria extracts stimulated release of IL-8 and TNFα, with concomitant reduction in TER; these effects were prevented by heat-treatment of the extracts. Examination of the effects of protease inhibitors suggested that serine proteases were the predominant class of proteases mediating these effects. ALI cultures from asthmatic donors exhibited a reduced IL-8 response to Alternaria relative to those from healthy controls, while neither responded with increased thymic stromal lymphopoietin (TSLP) release. Only cultures from asthmatic donors were susceptible to the barrier-weakening effects of Alternaria. Therefore, the bronchial epithelium of severely asthmatic individuals may be more susceptible to the deleterious effects of Alternaria.


Asunto(s)
Alérgenos/inmunología , Alternaria/inmunología , Antígenos Fúngicos/inmunología , Asma/inmunología , Bronquios/inmunología , Mucosa Respiratoria/inmunología , Asma/metabolismo , Asma/fisiopatología , Bronquios/metabolismo , Línea Celular , Citocinas/metabolismo , Impedancia Eléctrica , Activación Enzimática , Humanos , Mediadores de Inflamación/metabolismo , Péptido Hidrolasas/metabolismo , Permeabilidad/efectos de los fármacos , Inhibidores de Proteasas/farmacología , Mucosa Respiratoria/metabolismo , Mucosa Respiratoria/fisiopatología
12.
PLoS One ; 7(9): e44580, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22970254

RESUMEN

Rhinovirus (RV) infection is a major cause of asthma exacerbations which may be due to a deficient innate immune response in the bronchial epithelium. We hypothesized that the pleiotropic cytokine, TGF-ß, influences interferon (IFN) production by primary bronchial epithelial cells (PBECs) following RV infection. Exogenous TGF-ß(2) increased RV replication and decreased IFN protein secretion in response to RV or double-stranded RNA (dsRNA). Conversely, neutralizing TGF-ß antibodies decreased RV replication and increased IFN expression in response to RV or dsRNA. Endogenous TGF-ß(2) levels were higher in conditioned media of PBECs from asthmatic donors and the suppressive effect of anti-TGF-ß on RV replication was significantly greater in these cells. Basal SMAD-2 activation was reduced when asthmatic PBECs were treated with anti-TGF-ß and this was accompanied by suppression of SOCS-1 and SOCS-3 expression. Our results suggest that endogenous TGF-ß contributes to a suppressed IFN response to RV infection possibly via SOCS-1 and SOCS-3.


Asunto(s)
Bronquios/virología , Inmunidad Innata , Rhinovirus/fisiología , Factor de Crecimiento Transformador beta/fisiología , Replicación Viral/fisiología , Anticuerpos Neutralizantes/inmunología , Western Blotting , Bronquios/citología , Bronquios/inmunología , Electroforesis en Gel de Poliacrilamida , Ensayo de Inmunoadsorción Enzimática , Células Epiteliales/citología , Células Epiteliales/inmunología , Humanos , Reacción en Cadena en Tiempo Real de la Polimerasa , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Proteína 1 Supresora de la Señalización de Citocinas , Proteína 3 Supresora de la Señalización de Citocinas , Proteínas Supresoras de la Señalización de Citocinas/antagonistas & inhibidores , Proteínas Supresoras de la Señalización de Citocinas/biosíntesis , Factor de Crecimiento Transformador beta/inmunología
13.
BMJ Case Rep ; 20112011 Nov 08.
Artículo en Inglés | MEDLINE | ID: mdl-22674117

RESUMEN

Buckwheat is commonly consumed in many parts of the world and has recently become more available in the UK. Buckwheat allergy is well recognised in parts of mainland Europe and Asia, typically associated with consumption of specific regional foods. No adult cases of buckwheat allergy in the UK have been reported in the literature. The authors present two cases of buckwheat allergy that presented to our UK allergy service recently. A 57-year-old man presented with anaphylaxis after eating home-baked bread prepared using buckwheat flour bought in France. In the second case, a 63-year-old lady presented with bronchospasm and urticaria after consuming health-food muesli. Sensitisation was confirmed in both cases by positive skin prick testing and specific IgE to buckwheat. Given the growing popularity of foods that may contain buckwheat, including ethnic and health-food ranges, buckwheat allergy is likely to become increasingly common in the UK.


Asunto(s)
Fagopyrum/efectos adversos , Hipersensibilidad a los Alimentos/etiología , Fagopyrum/inmunología , Femenino , Hipersensibilidad a los Alimentos/epidemiología , Predicción , Humanos , Masculino , Persona de Mediana Edad , Reino Unido/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA